Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Entelos Stories

2013-09-03 23:23:45

CDER to Use Entelos Software to Explore Mechanisms of Drug-Induced Liver Injury San Mateo, CA (PRWEB) September 03, 2013 Entelos, a provider of in silico modeling and simulation products and consulting services, today announced a licensing agreement with the US Food and Drug Administration (FDA) for use of the PhysioLab Modeler software in its drug safety research. The license provides FDA with access to a computer model of drug-induced liver injury (DILI) that was developed under a 5...

2013-08-27 23:26:30

Seasoned pharmaceutical executive brings extensive expertise as company continues expansion and technology innovation. San Mateo, CA (PRWEB) August 27, 2013 Entelos, a premier provider of physiological system modeling and services that help pharmaceutical and consumer product companies predict better paths to success, today announced that Dr. Frank Armstrong, M.D. joins the Entelos Board of Directors. Dr. Armstrong has led medical science innovation and development teams in top...

2013-07-30 23:00:07

New physiological model provides platform for petfood manufacturers to better predict the nutritional effects of their products. San Mateo, California (PRWEB) July 31, 2013 Entelos, a premier provider of physiological system modeling and services that help pharmaceutical and consumer product companies predict better paths to success, today announced the availability of a new commercial quantitative physiological model that will enable petfood manufacturers to predict the effects of...

2013-06-20 23:03:22

Provider of predictive physiological simulations continues to transform modeling and simulation. San Mateo, CA (PRWEB) June 20, 2013 Entelos, a premier provider of physiological systems modeling and services that help pharmaceutical and consumer product companies predict better paths to success, today announced that it has received additional financing from its current investors Clearlake Capital Partners (Clearlake) and Michaelson Capital Partners (Michaelson). The financing will support...

2012-06-19 23:03:47

Making assumptions about the similarity of outcomes between laboratory species and humans is often disappointing after much investment of time and cost. Entelos´ ability to explain these phenomena through mechanism-based predictions is revolutionizing a fundamental translational research challenge. San Mateo, CA (PRWEB) June 19, 2012 Metabolism PhysioLab® Used to Compare Rodent to Human Data and Predict How and Why They Differ Entelos, a premier provider of in silico modeling and...

2008-07-11 12:01:04

Entelos has announced that Eli Lilly and Company has exercised its right to a perpetual license to Entelos's DrugMatrix database and additional customized report services from ToxFx. Entelos's DrugMatrix database is said to be a unique reference set of gene expression profiles for benchmark drugs and compounds that are linked to classic pharmacology, toxicology and clinical pathology measurements. It is populated with the comprehensive results of thousands of highly controlled and...